E3I ECLAUSion SIGNED

Project "E3I ECLAUSion" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

+-

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

E3I ECLAUSion, a joint venture between Ecole Centrale de Lyon (ECL) and RMIT University, Melbourne Australia aims to build a highly nurturing and multi-faceted PhD training environment that would benefit the emergence (‘eclosion’) of the next generation - 10 doctoral fellows in 2 cohorts- of not only highly skilled researchers but also entrepreneurs with an international mind-set and interdisciplinary training. Specifically ECLAUSion, in line with the MSCA guidelines, the EU principles for Innovative doctoral training and the code of conduct, aims to i) Reinforce research excellence in ECL in partnership with RMIT and increase scientific output and international visibility; ii) Expand on existing doctoral programs by attracting highly promising international early career researchers to ECL and providing a nurturing environment with global reach (both in terms of scientific supervision, mentoring, working conditions, administrative support and social life). We envision two calls being organized, with 5 doctoral contracts per call being offered (total number of PhDs offered 10) so that every researcher can receive their PhD degree during the 5 years program; iii) Educate and train these ESRs; enhance their research and transferable skills with a 3i dimension by offering them Interdisciplinary research options, exposure to Industry (both at local, regional and international levels), and an inherently International network to maximise their opportunities and their emergence into successful professionals in their future careers iv) Leverage the existing rich biotech and ICT local/regional/global ecosystem and capitalise on it to develop new synergies between academia and the private sectors and more generally v) Strengthen EU-Australia research collaboration in key areas for investment and growth in particular in Health; Biotechnology, Environment; Energy; Information and communications technologies; Nanotechnologies, materials and production technology.